ReviewCurrent opinion in pharmacology2022

Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming.

Kanchan Vishnoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.